Special Issue "Recent Advances in Plant Derived Anti-inflammatory Compounds"

A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Natural Products".

Deadline for manuscript submissions: 20 March 2024 | Viewed by 59

Special Issue Editor

Dr. David De Jong
E-Mail Website
Guest Editor
Genetics Department, Ribeirão Preto Medical School, University of São Paulo (FMRP/USP), Ribeirão Preto 14049-900, SP, Brazil
Interests: propolis; honey; Apis mellifera; Africanized bee; bee pathology; Varroa destructor; CCD (colony collapse disorder); bee nutrition
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Chronic inflammation is involved in the disease process of many conditions, including Alzheimer's disease, cancer, heart disease, arthritis, diabetes, and neurodegenerative diseases. Fortunately, many plant-derived compounds possess anti-inflammatory properties. Some well-known classes of plant-derived compounds with anti-inflammatory activity include polyphenols, terpenoids, and alkaloids. These compounds affect key molecules involved in the inflammatory response. For instance, curcumin, a bright yellow spice, inhibits nuclear factor-kappa, a regulator of inflammation. Resveratrol, found in grapes and red wine, can suppress pro-inflammatory cytokines. Many plant-derived compounds, including quercetin from onions and citrus fruits, as well as epigallocatechin gallate in green tea, also counteract oxidative stress—a common trigger of chronic inflammation. Plant-derived compounds, such as dietary fibers and prebiotics found in fruits, vegetables, and whole grains, influence the composition and activity of gut bacteria, modulating inflammation by promoting a healthy gut environment. Additionally, the Mediterranean diet, rich in plant-derived compounds like olive oil and vegetables, has been linked to a decreased risk of inflammatory diseases. Propolis, a natural product bees make from resins and other bioactive plant materials, blocks proinflammatory PAK1, a kinase highly expressed in COVID19 patients, and has been shown to reduce the impact of this disease. Continued research on bioactive plant compounds can help provide accessible and safe solutions for chronic inflammation. 

Dr. David De Jong
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers

This special issue is now open for submission.
Back to TopTop